AACR Annual Meeting 2018: Using Precision Medicine to Target RET-altered Cancers
While immunotherapy may be the latest tool in the treatment armamentarium for cancer, many ongoing clinical trials are assessing...
While immunotherapy may be the latest tool in the treatment armamentarium for cancer, many ongoing clinical trials are assessing...
The AACR Annual Meeting 2018 drew more than 22,600 people to Chicago, providing a front-row seat to some exciting...
A study presented at the AACR Annual Meeting 2018 discussed preliminary data on an off-the-shelf, T-cell receptor (TCR)-less, dual-targeted...
An exciting area in drug development, immunotherapy is being increasingly utilized by patients with different cancer types. These treatments...
This post originally appeared on the Cancer Today website. “This is a historic time in cancer research,” said Elizabeth...
As the 2018 Annual Meeting of the American Association for Cancer Research unfolded yesterday morning, the excitement among the...
The AACR’s Pediatric Cancer Working Group, which now boasts over 2,500 members, will hold a special scientific session at...
A study presented in the AACR Annual Meeting 2018 Media Preview webinar, held March 15, examined closely a key...
In less than a month, the AACR Annual Meeting 2018 will kick off in Chicago, Illinois. The meeting is...
Together with the Radiation Research Society, the AACR will present a workshop titled Targeting Cancer Metabolism to Improve Radiotherapy...